Detalles de la búsqueda
1.
Meta-analysis of sex and racial subgroup participation rates and differential treatment effects for trials in solid tumor malignancies leading to US Food and Drug Administration registration between 2010 and 2021.
Cancer
; 130(2): 276-286, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37751315
2.
Differential treatment effect between younger and older adults for new cancer therapies in solid tumors supporting US Food and Drug Administration approval between 2010 and 2021.
Cancer
; 129(20): 3318-3325, 2023 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37340792
3.
Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40-49.
BMC Womens Health
; 23(1): 75, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36803461
4.
Resource stratified guidelines for cancer: Are they all the same? Interguideline concordance for systemic treatment recommendations.
Int J Cancer
; 150(1): 91-99, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34398966
5.
Optimism Bias in the Design of Phase III Randomized Control Trials Evaluating PD-1/PD-L1 Targeting Monoclonal Antibodies.
Oncologist
; 27(6): 487-492, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35278074
6.
Cancer Risk and Mortality in Patients With Kidney Disease: A Population-Based Cohort Study.
Am J Kidney Dis
; 80(4): 436-448.e1, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405208
7.
Regional Variations in Clinical Trial Outcomes in Oncology.
J Natl Compr Canc Netw
; 20(8): 879-886.e2, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35948036
8.
Patient and provider determinants of breast cancer screening among Ontario women aged 40-49: a population-based retrospective cohort study.
Breast Cancer Res Treat
; 189(3): 631-640, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34414531
9.
Quantifying Withdrawal of Consent, Loss to Follow-Up, Early Drug Discontinuation, and Censoring in Oncology Trials.
J Natl Compr Canc Netw
; 19(12): 1433-1440, 2021 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34479210
10.
Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period.
J Natl Compr Canc Netw
; : 1-9, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34560672
11.
A prospective multi-centre, randomized study comparing the addition of tapering dexamethasone to other standard of care therapies for taxane-associated pain syndrome (TAPS) in breast cancer patients.
Support Care Cancer
; 29(10): 5787-5795, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33742240
12.
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates.
Breast Cancer Res
; 22(1): 15, 2020 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32005279
13.
Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration.
Cancer
; 126(19): 4390-4399, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32697362
14.
Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer.
Breast Cancer Res Treat
; 182(2): 259-266, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32488391
15.
Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study.
Eur Heart J
; 40(48): 3913-3920, 2019 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31318428
16.
Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines.
Cancer
; 125(22): 4069-4075, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31355923
17.
A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229).
Oncologist
; 24(11): 1439-1445, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420468
18.
Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysis.
Breast Cancer Res Treat
; 175(3): 531-545, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30929116
19.
Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
J Surg Oncol
; 119(7): 932-940, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30838647
20.
Role of Bisphosphonates in Breast Cancer Therapy.
Curr Treat Options Oncol
; 20(4): 26, 2019 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30874905